<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">NPJ Parkinsons Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">NPJ Parkinsons Dis</journal-id>
      <journal-title-group>
        <journal-title>NPJ Parkinson's Disease</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2373-8057</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34272398</article-id>
      <article-id pub-id-type="pmc">8285494</article-id>
      <article-id pub-id-type="publisher-id">205</article-id>
      <article-id pub-id-type="doi">10.1038/s41531-021-00205-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Abnormal interhemispheric resting state functional connectivity in Parkinson’s disease patients with impulse control disorders</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Gan</surname>
            <given-names>Caiting</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Wang</surname>
            <given-names>Lina</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Ji</surname>
            <given-names>Min</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>Kewei</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>Huimin</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4437-1095</contrib-id>
          <name>
            <surname>Zhang</surname>
            <given-names>Kezhong</given-names>
          </name>
          <address>
            <email>kezhong_zhang1969@126.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Yuan</surname>
            <given-names>Yongsheng</given-names>
          </name>
          <address>
            <email>da_sheng@126.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.412676.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1799 0784</institution-id><institution>Department of Neurology, </institution><institution>The First Affiliated Hospital of Nanjing Medical University, </institution></institution-wrap>Nanjing, China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>7</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>16</day>
        <month>7</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>7</volume>
      <elocation-id>60</elocation-id>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>1</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>6</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© The Author(s) 2021</copyright-statement>
        <license>
          <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Impulse control disorders (ICD) in Parkinson’s disease (PD) might be attributed to misestimate of rewards or the failure to curb inappropriate choices. The mechanisms underlying ICD were reported to involve the lateralization of monoamine network. Our objective was to probe the significant role of lateralization in the pathogenesis of ICD. Twenty-one PD patients with ICD (PD-ICD), thirty-three without ICD (PD-no ICD), and thirty-seven healthy controls (HCs) were recruited and performed T1-weighted, diffusion tensor imaging (DTI) scans and resting state functional magnetic resonance imaging (rs-fMRI). By applying the Voxel-mirrored Homotopic Connectivity (VMHC) and Freesurfer, we evaluated participants’ synchronicity of functional connectivity and structural changes between hemispheres. Also, tract-based spatial statistics (TBSS) was applied to compare fiber tracts differences. Relative to PD-no ICD group, PD-ICD group demonstrated reduced VMHC values in middle frontal gyrus (MFG). Compared to HCs, PD-ICD group mainly showed decreased VMHC values in MFG, middle and superior orbital frontal gyrus (OFG), inferior frontal gyrus (IFG) and caudate, which were related to reward processing and inhibitory control. The severity of impulsivity was negatively correlated with the mean VMHC values of MFG in PD-ICD group. Receiver operating characteristic (ROC) curves analyses uncovered that the mean VMHC values of MFG might be a potential marker identifying PD-ICD patients. However, we found no corresponding asymmetrical alteration in cortical thickness and no significant differences in fractional anisotropy (FA) and mean diffusivity (MD). Our results provided further evidence for asymmetry of functional connectivity in mesolimbic reward and response inhibition network in ICD.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Parkinson's disease</kwd>
        <kwd>Parkinson's disease</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id>
              <institution>National Natural Science Foundation of China (National Science Foundation of China)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>81671258</award-id>
          <award-id>81901297</award-id>
          <principal-award-recipient>
            <name>
              <surname>Zhang</surname>
              <given-names>Kezhong</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>Yongsheng</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2021</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p id="Par2">Impulse control disorders (ICD), including pathological gambling (PG), binge eating (BE), compulsive shopping (CS), and hypersexuality (HS)<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>, are reported in 6.1–31.2% of Parkinson’s disease (PD) patients<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>, occurring primarily in patients treated with dopamine receptor agonists. PD patients with ICD are more prone to anxiety, depression, apathy and other mental disorders than patients without, and the severity of mental symptoms increases synchronously with the number of ICD<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. ICD can lead to severe personal, family, economic and psychosocial burden, attracting more and more attention from researchers and clinicians.</p>
      <p id="Par3">Although the pathogenesis of ICD in PD patients remains unclear, emerging evidence supports that a complex multifactorial mechanism of serotoninergic and noradrenergic interaction was involved in the development of ICD, beyond the classical dopaminergic corticostriatal networks<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Namely, the presence of ICD could be ascribed to the engagement of reward and response inhibition networks, mediated by frontostriatal connectivity<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. Susceptibility to the disease depends on related risk factors, such as younger age at onset, early PD onset, unmarried, cigarette smoking, caffeine use, treatment related, personal or family history, and the occurrence of motor complications<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Recently, a cross-sectional study suggested that right onset of PD might also be a risk factor for ICD<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Simultaneously, a DATSCAN imaging research supported that ICD symptoms were linked to the disruption of asymmetric molecular frontostriatal network centered on left basal ganglia, fitting well with the effect of left-hemisphere activity during reward processing<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. These above findings implied that the laterality of dopamine and serotonin network might have significant influence on ICD. Based on these previous results, we intended to probe the important role of lateralization in the pathogenesis of ICD by more intuitively exploration of functional connectivity between hemispheres.</p>
      <p id="Par4">Thus, we adopted a validated analysis approach named Voxel-mirrored Homotopic Connectivity (VMHC), which could detect the altered interhemispheric connectivity via quantifying functional connections between each voxel in one hemisphere and its corresponding voxel in the other<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. This is a well-established approach that has been widely applied in the studies of many diseases. Prior to our study, numerous neuropsychiatric diseases have been investigated using this method to reveal the functional coordination between hemispheres<sup><xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR13">13</xref></sup>. In general, a decrease in VMHC values represents a decrease in synchronicity between the two cerebral hemispheres, which could be interpreted as the possible presence of functional laterality. Furthermore, it is generally believed that changes of functional connectivity might be correlated with alterations of structure. Hence, we further analyzed whether the desynchronized brain regions of functional connections also showed asymmetry in cortical thickness. Meanwhile, diffusion tensor imaging (DTI) was also applied in our study to detect fiber tracts impairment.</p>
    </sec>
    <sec id="Sec2" sec-type="results">
      <title>Results</title>
      <sec id="Sec3">
        <title>Demographic and clinical characteristics</title>
        <p id="Par5">Subjects were divided into three groups: 21 PD patients with ICD (PD-ICD), 33 PD patients without ICD symptoms (PD-no ICD), and 37 healthy controls (HCs). Clinical characteristics of PD subgroups and HCs are demonstrated in Table <xref rid="Tab1" ref-type="table">1</xref>. No remarkable differences were observed in age, gender, and education. In relative to PD-no ICD group, the PD-ICD group revealed no significant differences in disease duration, age at onset, affected side at onset, Hoehn &amp; Yahr stage (H-Y stage) scale, the Unified Parkinson’s Disease Rating Scale Section III (UPDRS-III), Barratt Impulsiveness Scale (BIS), total levodopa equivalent daily dose and levodopa equivalent daily dose of dopamine agonist. Unsurprisingly, ICD symptom severity worsened in PD-ICD group than PD-no ICD (p &lt; 0.0001). Notably, 19 patients in PD-ICD group showed a single ICD and 2 cases had multiple impulse control and related disorders (ICD-RD). CS was the most frequent disorder (7/21, 33.3%), followed by BE (5/21, 23.8%), PG (5/21, 23.8%), HS (2/21, 9.5%), BE + CS + Hobbyism-punding (1/21, 4.8%), and CS + DDS (1/21, 4.8%). Mini Mental State Examination (MMSE) scores of HCs were significantly higher than that of PD-ICD and PD-no ICD groups (<italic>p</italic> = 0.015 and <italic>p</italic> = 0.006, respectively) after Bonferroni post-hoc test. Similarly, Hamilton Anxiety Scale (HAMA) and Hamilton Depression Scale-24 (HAMD-24) scores in HCs group were significantly lower in relative to PD-ICD and PD-no ICD groups (<italic>p</italic> &lt; 0.0001).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographic and clinical characteristics of the studied groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th>PD-ICD (<italic>n</italic> = 21)</th><th>PD-noICD (<italic>n</italic> = 33)</th><th>HCs (<italic>n</italic> = 37)</th><th><italic>p</italic></th><th>Post hoc (Bonferroni)</th></tr></thead><tbody><tr><td>Age (y)</td><td>59.0 ± 9.6</td><td>61.7 ± 9.3</td><td>62.0 ± 5.6</td><td>0.378<sup>b</sup></td><td/></tr><tr><td>Gender (M/F)</td><td>12/9</td><td>20/13</td><td>25/12</td><td>0.700<sup>a</sup></td><td/></tr><tr><td>Education (y)</td><td>11.4 ± 3.1</td><td>10.3 ± 3.3</td><td>12.2 ± 3.8</td><td>0.085<sup>c</sup></td><td/></tr><tr><td>Disease duration (y)</td><td>9.0 ± 5.2</td><td>7.1 ± 3.0</td><td>—</td><td>0.241<sup>d</sup></td><td/></tr><tr><td>Age at onset (y)</td><td>50.9 ± 10.1</td><td>54.2 ± 9.7</td><td>—</td><td>0.235<sup>e</sup></td><td/></tr><tr><td>Affected side at onset right% (n)</td><td>47.6% (10)</td><td>42.4% (14)</td><td>—</td><td>0.708<sup>a</sup></td><td/></tr><tr><td>UPDRS part 3</td><td>20.3 ± 14.2</td><td>18.5 ± 11.3</td><td>—</td><td>0.518<sup>d</sup></td><td/></tr><tr><td>H-Y stage</td><td>2.3 ± 0.7</td><td>2.2 ± 0.6</td><td>—</td><td>0.580<sup>d</sup></td><td/></tr><tr><td>LEDD<sub>TOTAL</sub> (mg)</td><td>770.7 ± 310.8</td><td>636.1 ± 271.5</td><td>—</td><td>0.085<sup>d</sup></td><td/></tr><tr><td>LEDD<sub>DA</sub> (mg)</td><td>90.5 ± 57.4</td><td>68.6 ± 50.7</td><td>—</td><td>0.150<sup>e</sup></td><td/></tr><tr><td>DA %</td><td>85.70%</td><td>78.50%</td><td>—</td><td>0.523<sup>a</sup></td><td/></tr><tr><td>QUIP-RS total score</td><td>13.0 ± 5.9</td><td>0</td><td>—</td><td>&lt;0.0001<sup>d, ***</sup></td><td/></tr><tr><td>BIS</td><td>33.1 ± 15.6</td><td>29.7 ± 15.3</td><td>—</td><td>0.495<sup>d</sup></td><td/></tr><tr><td>MMSE</td><td>28.3 ± 1.1</td><td>28.0 ± 1.5</td><td>29.1 ± 0.9</td><td>0.002<sup>c, **</sup></td><td>PD-ICD &lt; HC (<italic>p</italic> = 0.015) PD-noICD &lt; HC (<italic>p</italic> = 0.006)</td></tr><tr><td>HAMA</td><td>14.0 ± 8.9</td><td>11.2 ± 6.1</td><td>2.3 ± 3.3</td><td>&lt;0.0001<sup>c, ***</sup></td><td>PD-ICD &lt; HC (<italic>p</italic> &lt; 0.0001) PD-noICD &lt; HC (<italic>p</italic> &lt; 0.0001)</td></tr><tr><td>HAMD-24</td><td>12.6 ± 8.2</td><td>9.5 ± 7.0</td><td>1.7 ± 2.5</td><td>&lt;0.0001<sup>c, ***</sup></td><td>PD-ICD &lt; HC (<italic>p</italic> &lt; 0.0001) PD-noICD &lt; HC (<italic>p</italic> &lt; 0.0001)</td></tr><tr><td>FAB</td><td>16.2 ± 2.0</td><td>16.4 ± 2.5</td><td>17.0 ± 1.3</td><td>0.232<sup>c</sup></td><td/></tr></tbody></table><table-wrap-foot><p>Values are presents as the mean ± standard deviation.</p><p><italic>PD</italic> Parkinson’s Disease, <italic>ICD</italic> impulse control disorders, <italic>HCs</italic> healthy controls, <italic>M</italic> male, <italic>F</italic> female, <italic>y</italic> year, <italic>UPDRS</italic> Unified Parkinson’s disease rating scale, <italic>H-Y stage</italic> Hoehn and yahr clinical rating scale, <italic>LEDD</italic><sub><italic>TOTAL</italic></sub> total levodopa equivalent daily dose, <italic>LEDD</italic><sub><italic>DA</italic></sub> levodopa equivalent daily dose of dopamine agonist, <italic>DA</italic> dopamine agonist, <italic>QUIP-RS</italic> Questionnaire for Impulsive Compulsive Disorders in Parkinson’s Disease-Rating Scale, <italic>BIS</italic> Barratt Impulsiveness Scale, <italic>MMSE</italic> Mini Mental State Examination, <italic>HAMA</italic> Hamilton Anxiety Scale, <italic>HAMD-24</italic> Hamilton Depression Scale-24, <italic>FAB</italic> Frontal Assessment Battery.</p><p><sup>a</sup>Chi-square test.</p><p><sup>b</sup>One-way ANOVA.</p><p><sup>c</sup>Kruskal-Wallis.</p><p><sup>d</sup>Mann-Whitney U.</p><p><sup>e</sup>Two-sample t-test.</p><p>*<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001.</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec4">
        <title>Voxel-mirrored homotopic connectivity</title>
        <p id="Par6">Analysis of covariance (ANCOVA) was utilized to detected the VMHC differences among the three groups, following by the two-sample post hoc t-test. PD-ICD patients demonstrated reduced VMHC values in middle frontal gyrus (MFG) (MNI <italic>x</italic> = ± 45, <italic>y</italic> = 9, <italic>z</italic> = 57, T value = −3.6619) in relative to PD-no ICD group, after adjusting gender, age, education level, mean framewise displacement (FD), HAMA, HAMD-24 and MMSE scores. Compared with HCs, significant reduced VMHC values were founded in MFG (MNI <italic>x</italic> = ± 45, <italic>y</italic> = 9, <italic>z</italic> = 57, T value = −3.5509), inferior frontal gyrus (IFG) (MNI <italic>x</italic> = ± 60, <italic>y</italic> = 12, <italic>z</italic> = 9, T value = −3.6203), middle orbital frontal gyrus (MNI <italic>x</italic> = ± 24, <italic>y</italic> = 54, <italic>z</italic> = −18, T value = −3.8517) and superior orbital frontal gyrus (OFG) (MNI <italic>x</italic> = ± 15, <italic>y</italic> = 18, <italic>z</italic> = −18, T value = −3.4832), middle temporal gyrus (MNI <italic>x</italic> = ± 69, <italic>y</italic> = −30, <italic>z</italic> = −12, T value = −4.0977) and superior temporal gyrus (MNI <italic>x</italic> = ± 66, <italic>y</italic> = −27, <italic>z</italic> = 12, T value = −3.5061), caudate (MNI <italic>x</italic> = ± 12, <italic>y</italic> = 9, <italic>z</italic> = 6, T value = −3.3566), precentral (MNI <italic>x</italic> = ± 33, <italic>y</italic> = −21, <italic>z</italic> = 69, T value = −4.3051), and angular (MNI <italic>x</italic> = ± 42, <italic>y</italic> = −69, <italic>z</italic> = 42, T value = −3.4986) in the PD-ICD group. And PD-no ICD patients presented significant decreased VMHC values in the middle temporal gyrus (MNI <italic>x</italic> = ± 57, <italic>y</italic> = −63, <italic>z</italic> = 3, T value = −3.4022), superior orbital frontal gyrus (MNI <italic>x</italic> = ± 12, <italic>y</italic> = 24, <italic>z</italic> = −24, T value = −4.6984), superior cerebellum (MNI <italic>x</italic> = ± 33, <italic>y</italic> = −78, <italic>z</italic> = −21, T value = −3.9719), and postcentral gyrus (MNI <italic>x</italic> = ± 54, <italic>y</italic> = −21, <italic>z</italic> = 45, T value = −3.9756) compared to HCs (Fig. <xref rid="Fig1" ref-type="fig">1</xref> and Table <xref rid="Tab2" ref-type="table">2</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>Statistical maps showing VMHC differences in different brain regions among three groups.</title><p>The threshold for display was set to <italic>p</italic> &lt; 0.01. <italic>PD</italic> Parkinson’s Disease, <italic>VMHC</italic> voxel-mirrored homotopic connectivity, <italic>ICD</italic> Impulse control disorders, <italic>HCs</italic> health controls, <italic>R</italic> right, <italic>L</italic> left.</p></caption><graphic xlink:href="41531_2021_205_Fig1_HTML" id="d32e989"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>VMHC differences among PD-ICD patients, PD-no ICD patients, and health controls during ON phase.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Brain regions (AAL)</th><th rowspan="2">Number of voxels</th><th colspan="3">MNI Coordinates</th><th rowspan="2">BA</th><th rowspan="2">T Value</th></tr><tr><th>X</th><th>Y</th><th>Z</th></tr></thead><tbody><tr><td colspan="7">PD-ICD vs PD-no ICD</td></tr><tr><td>Middle frontal gyrus</td><td>18</td><td>±45</td><td>9</td><td>57</td><td>6</td><td>−3.6619</td></tr><tr><td colspan="7">PD-ICD vs HCs</td></tr><tr><td>Middle frontal gyrus</td><td>30</td><td>±45</td><td>9</td><td>57</td><td>6</td><td>−3.5509</td></tr><tr><td>Middle orbital frontal gyrus</td><td>157</td><td>±24</td><td>54</td><td>−18</td><td>11</td><td>−3.8517</td></tr><tr><td>Superior orbital frontal gyrus</td><td>42</td><td>±15</td><td>18</td><td>−18</td><td>11</td><td>−3.4832</td></tr><tr><td>Caudate</td><td>25</td><td>±12</td><td>9</td><td>6</td><td>—</td><td>−3.3566</td></tr><tr><td>Inferior frontal gyrus (pars opercularis)</td><td>66</td><td>±60</td><td>12</td><td>9</td><td>6</td><td>−3.6203</td></tr><tr><td>Middle temporal gyrus</td><td>98</td><td>±69</td><td>−30</td><td>−12</td><td>21</td><td>−4.0977</td></tr><tr><td>Superior temporal gyrus</td><td>26</td><td>±66</td><td>−27</td><td>12</td><td>22</td><td>−3.5061</td></tr><tr><td>Precental gyrus</td><td>90</td><td>±33</td><td>−21</td><td>69</td><td>6</td><td>−4.3051</td></tr><tr><td>Angular gyrus</td><td>36</td><td>±42</td><td>−69</td><td>42</td><td>7</td><td>−3.4986</td></tr><tr><td colspan="7">PD-no ICD vs HCs</td></tr><tr><td>Superior orbital frontal gyrus</td><td>92</td><td>±12</td><td>24</td><td>−24</td><td>11</td><td>−4.6984</td></tr><tr><td>Superior cerebelum</td><td>175</td><td>±33</td><td>−78</td><td>−21</td><td>19</td><td>−3.9719</td></tr><tr><td>Middle temporal gyrus</td><td>76</td><td>±57</td><td>−63</td><td>3</td><td>37</td><td>−3.4022</td></tr><tr><td>Postcentral gyrus</td><td>172</td><td>±54</td><td>−21</td><td>45</td><td>3</td><td>−3.9756</td></tr></tbody></table><table-wrap-foot><p>The resulting statistical maps were set at <italic>p</italic> &lt; 0.01 and corrected by AlphaSim. <italic>VMHC</italic> Voxel-mirrored Homotopic Connectivity, <italic>PD</italic> Parkinson’s disease, <italic>ICD</italic> Impulse control disorders, <italic>HCs</italic> healthy controls, <italic>AAL</italic> Anatomical Automatic Labeling, <italic>BA</italic> Brodmann area.</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec5">
        <title>Cortical thickness</title>
        <p id="Par7">The asymmetry index (AI) was not different between groups restricted to the brain regions showing VMHC differences after Bonferroni correction (Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>).</p>
      </sec>
      <sec id="Sec6">
        <title>Tract-based spatial statistics</title>
        <p id="Par8">Tract-based spatial statistics (TBSS) was applied to compare fiber tracts impairment across the whole brain among these three groups. However, no significant differences were detected among the groups (Supplementary Fig. <xref rid="MOESM1" ref-type="media">1</xref>).</p>
      </sec>
      <sec id="Sec7">
        <title>Correlation analysis</title>
        <p id="Par9">Correlation analysis showed a negative relationship between Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease rating scale (QUIP-RS) scores and mean VMHC values of the MFG in PD-ICD group (<italic>r</italic> = −0.625, <italic>p</italic> = 0.013, Fig. <xref rid="Fig2" ref-type="fig">2a</xref>), indicating that with the aggravation of ICD symptoms, the function coordination of the MFG became poorer.<fig id="Fig2"><label>Fig. 2</label><caption><title>Correlation between VMHC values and QUIP-RS scores of PD-ICD patients and ROC analyses for differentiating different groups.</title><p>Scatterplots demonstrated that there was a significant negative correlation between the mean VMHC values in the middle frontal gyrus and QUIP-RS scores in PD patients with ICD. The graph showed the results of the ROC analyses for differentiating different groups. VMHC voxel-mirrored homotopic connectivity, <italic>QUIP-RS</italic> Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease Rating Scale, <italic>PD</italic> Parkinson’s Disease, <italic>ICD</italic> impulse control disorders, <italic>ROC</italic> receiver operating characteristic, <italic>AUC</italic> area under the curve, <italic>CI</italic> confidence interval, <italic>HCs</italic> healthy controls.</p></caption><graphic xlink:href="41531_2021_205_Fig2_HTML" id="d32e1441"/></fig></p>
        <p id="Par10">In addition, as illustrated in Table <xref rid="Tab3" ref-type="table">3</xref> and Fig. <xref rid="Fig2" ref-type="fig">2b</xref>, receiver operating characteristic (ROC) analyses revealed that the area under the curve (AUC) of the MFG was 0.736 when separating PD-ICD patients from the PD-no ICD patients (95% confidence interval [CI]: 0.5954–0.8735, <italic>p</italic> = 0.004). Meanwhile, the AUC of the MFG was 0.802 when PD-ICD patients were separated from HCs (95% CI: 0.6885–0.9151, <italic>p</italic> &lt; 0.001).<table-wrap id="Tab3"><label>Table 3</label><caption><p>ROC analyses for differentiating different groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Brain regions</th><th>AUC</th><th><italic>p</italic> value</th><th>95% CI</th><th>Sensitivity</th><th>Specificity</th><th>Cut-off point</th></tr></thead><tbody><tr><td colspan="7">Middle frontal gyrus</td></tr><tr><td> Separating PD-ICD from PD-no ICD</td><td>0.736</td><td>0.004<sup>**</sup></td><td>0.5954–0.8735</td><td>0.667</td><td>0.788</td><td>0.1243</td></tr><tr><td> Separating PD-ICD from HCs</td><td>0.802</td><td>&lt;0.001<sup>***</sup></td><td>0.6885–0.9151</td><td>0.702</td><td>0.810</td><td>0.2126</td></tr><tr><td> Separating PD-no ICD from HCs</td><td>0.589</td><td>0.202</td><td>0.4519–0.7258</td><td>0.568</td><td>0.697</td><td>0.2468</td></tr></tbody></table><table-wrap-foot><p><italic>ROC</italic> receiver operating characteristic, <italic>AUC</italic> area under the curve, <italic>CI</italic> confidence interval, <italic>PD</italic> Parkinson’s disease, <italic>ICD</italic> Impulse control disorders, <italic>HCs</italic> healthy controls.</p><p>*<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001.</p></table-wrap-foot></table-wrap></p>
      </sec>
    </sec>
    <sec id="Sec8" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par11">We postulated that brain laterality may act as a key role in the pathogenesis of ICD, and hypothesized that laterality occurred primarily in brain regions associated with reward and response inhibition networks in the present study. Actually, we discovered that PD-ICD group had reduced VMHC values of MFG, relative to those without ICD symptoms. Compared to HCs, PD-ICD group principally showed decreased VMHC values in MFG, middle and superior OFG, IFG, and caudate. Further, the higher was the severity of ICD, the lower were the mean VMHC values of MFG. Besides, ROC analyses showed that the reduced VMHC values of MFG could be utilized to distinguish PD-ICD from PD-no ICD and HCs groups. However, we did not observe morphologic alterations of cortical thickness and fiber tracts among the three groups. Therefore, we supposed that interhemispheric function desynchronization was irrelevant to cortical thickness and fiber tracts alterations, and that changes in functional synchronization of ICD had not result in alteration of cortical thickness and fiber tracts. These above multiparametric magnetic resonance imaging (MRI) findings might afford a new perspective to understand the neural substrates underlying ICD.</p>
      <p id="Par12">As components of prefrontal network, the MFG, OFG, and IFG were considered as key nodes in motor inhibition network, which could suppress the reaction to incongruous stimulation by overriding the motor system’s automatic response tendency<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. It is well known that inhibitory control was a vital executive function, involved in restraining a prepotent response or allowing proper actions to fulfill intricate task requirements and adapt to varying environment<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. Meanwhile, the caudate was also indispensable during the successful response inhibition which was implicated in preventing the automatic execution of an action<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. On the other hand, caudate is one of reward-related regions responding to general reward processing and its impairment could lead to be hard to inhibit aberrant behaviors in spite of the predictable negative outcomes<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup>. Indeed, suppressing an ongoing initiated reaction could be intensely dependent on the frontal striatum pathway<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, thus the disruption of this loop in PD-ICD patients may bring about lessening resistance to instant rewards, regardless of long-term consequences<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. ICD in PD has previously been reported as a multidimensional concept that includes the changes of reward processing, inhibition control, learning from reward and loss, and conflict processing<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Although the caudate was the result of ICD compared with HCs, we did not find this brain region when comparing no-ICD with HCs. Combined with previous research findings, our results further confirmed that the pathogenesis of ICD was related to reward and inhibition systems. Moreover, it is worth noting that our results can complement previous studies, which have not emphasized the critical role of lateralization of response inhibition and reward system in ICD. In fact, the thinning of the corpus callosum was found by Roberta et al. in PD patients with ICD<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Concerning that the corpus callosum is the largest white matter structure connecting the two hemispheres of the brain, previous research suggested that the structure alterations of corpus callosum are associated with compromised interhemispheric functional communications<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. Therefore, the reduced VMHC of regions primarily involved in inhibitory control and reward networks detected in our study might reflect uncoordinated inhibition control and reward processing in PD-ICD group. Hence, we hypothesized that disconnection and imbalance of impulsivity and inhibitory might be an important mechanism for inducing ICD. In accordance with our hypothesis, imaging researches of PG demonstrated right lateralized reward system alteration, specifically, the changes only detected in the right ventral striatum in answer to gambling stimuli<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> as well as the processing of monetary reward<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. In another study, PD-ICD patients exhibited abnormality limited to the right cerebral cortex and subcortical regions involving reward processing and inhibitory control<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Furthermore, we explored the correlation between VMHC values of MFG and impulsiveness symptom severity within the PD-ICD group to confirm whether connectivity-based findings were related to behavioral measures. Our findings revealed that QUIP-RS scores were negatively correlated with the mean VMHC values of MFC. That is, when patients’ clinical syndromes were more serious, their QUIP-RS scores increased, and their ICD symptoms severity might be associated with the impaired MFC function. Besides, the ROC analyses revealed that the mean VMHC values of MFG could identify the PD-ICD patients from PD-no ICD patients or HCs, which might be used as a potential feature of PD patients with ICD.</p>
      <p id="Par13">In interpreting the present findings, several limitations are worth considering. First, all of the patients underwent the MRI scanning during the “ON” medication state. Nevertheless, previous study suggested that dopaminergic treatments modulated the functional connectivity. In our investigation, the PD-ICD group had a little higher total levodopa equivalent daily dose (LEDD<sub>TOTAL</sub>) relative to PD-no ICD group without statistically significant. Thus, we cannot rule out the impact of pharmacological treatment on the discoveries of functional connectivity. Yet, the literature we consulted before conducting the study supported MRI scanning of ICD patients during “ON” state<sup><xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR26">26</xref></sup>. Further, ICD specific mechanism could be more likely to be detected during “ON” phase, since that ICD symptoms were closely related to dopamine replacement therapy. Technically speaking, taking medication can reduce unnecessary movements in patients and therefore limit possible movement-related artifacts. Second, the PD-ICD samples enrolled in our study were heterogeneous and could have neglected some findings specific to a single ICD category. Our finding may be driven by CS since the large proportion of it. On account of the sample size limitation, we did not perform a separate analysis for a single ICD presentation. So future studies concentrated on single ICD are urgently needed to illustrate their respective clinicoradiological correlations. Third, VMHC is methodologically limited in that it is unable to investigate the internal functional connectivity of the hemisphere or verdict which side of the brain is impaired. Fourth, the clinical data of the subjects we included did not exactly match. HAMA, HAMD-24, and MMSE scores in HCs were significantly different from those in PD with or without ICD. But when analyzing the data, we had included these as covariates to minimize their impact on the results.</p>
      <p id="Par14">In conclusion, our findings of the neural laterality of reward and inhibitory system may make further understanding of the pathophysiological mechanisms of ICD behaviors in PD.</p>
    </sec>
    <sec id="Sec9">
      <title>Methods</title>
      <sec id="Sec10">
        <title>Subjects</title>
        <p id="Par15">The final study included 93 participants recruiting from the Neurology Department of the First Affiliated Hospital of Nanjing Medical University, Nanjing, China. There were 23 PD patients with ICD (PD-ICD), 33 PD patients without ICD symptoms (PD-no ICD), and 37 healthy controls (HCs). Participants were matched for sex, age, intelligence, and education. All patients were diagnosed on the basis of United Kingdom Parkinson’s Disease Society Brain Bank criteria and were screened for the presence of ICD according to the Diagnostic and Statistical Manual of Mental Disorders research criteria and the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease (QUIP)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. This diagnosis was double-confirmed during the semi-structured interview with a neurologist, using standardized criteria for PG, HS, BE, and CS<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. In the PD-ICD group, twenty-three patients had at least one current ICD symptom that developed after PD diagnosis and initiation of dopamine replacement therapy. Further, we assessed the severity of ICD by the QUIP-RS and each ICD patients had a QUIP-RS score above the critical value for at least one ICD subtype<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>. Details of each PD patients’ ICD characteristics were described in Supplementary Table <xref rid="MOESM1" ref-type="media">2</xref>. In addition, we also confirmed that HCs and patients in PD-no ICD group had never experienced an ICD by their negative responses to QUIP. Thirty-seven controls were recruited from hospital personnel, non-consanguineous relatives and society.</p>
        <p id="Par16">Exclusion criteria were: (1) history of alcohol or drug addiction; (2) any neuropsychiatric disorders other than PD, especially severe depression, obsessive-compulsive and bipolar disorders; (3) serious cardiovascular, metabolic or neurosurgical procedures (including deep brain stimulation) or infusion therapies (duodenal levodopa or apomorphine infusion); (4) severe visual hallucinations interfering with clinical and neuropsychological assessments; (5) ICD patients were not symptomatic during examination; (6) dyskinesia complications; (7) evidence of brain anatomical abnormalities at routine MRI; (8) contraindications of MRI scans. Furthermore, all PD patients should have stable dopaminergic therapy at least two months. Prior to enrollment, approval was obtained by the ethics committee of the First Affiliated Hospital of Nanjing Medical University and written informed consent were signed by all participants.</p>
      </sec>
      <sec id="Sec11">
        <title>Demographic and clinical assessment</title>
        <p id="Par17">All PD patients were evaluated during ON phase when the dopaminergic medication was active and symptoms were well controlled. We assessed their disease stage and severity using the H-Y stage scale and the UPDRS-III, respectively. In addition, we calculated dopamine agonist equivalent daily dose (LEDD<sub>DA</sub>) and LEDD<sub>TOTAL</sub> according to the previous literature<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. We conducted a comprehensive assessment of the patients including mental symptoms (HAMD-24, HAMA, and BIS) and cognitive situation [Frontal Assessment Battery (FAB) and MMSE]. Demographic information including age, gender, education level, disease duration, age at diagnosis, and affected side at onset were also collected.</p>
      </sec>
      <sec id="Sec12">
        <title>MRI data acquisition</title>
        <p id="Par18">All patients underwent MRI scanning in the morning while they were still under the effect of regular dopaminergic medication dose. Meanwhile, all participants were explicitly informed to remain motionless, and not to think about anything special. MRI scans were accessed on a 3.0 T Siemens MAGNETOM Verio whole-body MRI system (Siemens Medical Solutions, Germany). Three-dimensional T1-weighted anatomical images were collected using the following volumetric 3D magnetization-prepared rapid gradient-echo (MP-RAGE) sequence: repetition time [TR] = 1900 ms, echo time [TE] = 2.95 ms, flip angle [FA] = 9°, thickness = 1 mm, slices = 160, field of view [FOV] = 230 × 230 mm<sup>2</sup>, acquisition matrix = 256 × 256 and voxel size = 1 × 1 × 1 mm<sup>3</sup>. Resting-state functional images were acquired using an echo-planar imaging (EPI) sequence with the following parameters: TR = 2000 ms, TE = 21 ms, FA = 90°, FOV = 256 × 256 mm<sup>2</sup>, in-plane matrix = 64 × 64, slices = 35, thickness = 3 mm, gap = 0 mm, voxel size = 3 × 3 × 3 mm<sup>3</sup>, total volumes = 240.</p>
      </sec>
      <sec id="Sec13">
        <title>Preprocessing of fMRI data analysis and voxel-mirrored homotopic connectivity</title>
        <p id="Par19">Rs-fMRI data preprocessing was analyzed by the Data Processing Assistant for Resting-State fMRI (DPARSF, <ext-link ext-link-type="uri" xlink:href="http://www.restfmri.net/forum/dparsf">http://www.restfmri.net/forum/dparsf</ext-link>) and REST (<ext-link ext-link-type="uri" xlink:href="http://restfmri.net">http://restfmri.net</ext-link>). The steps were summarized as follows: (1) discard the first ten time points and correct time differences between slice and head motion (Friston 24 parameter), (2) co-register T1 structural images to the mean EPI scans, (3) spatial normalization and re-sample to 3 × 3 × 3 mm<sup>3</sup>, (4) spatial smooth with a 6 mm full width half maximum Gaussian kernel, (5) filter (0.01–0.08 Hz) and remove linearly detrended, (6) regress nuisance signals [six head motion parameters, white matter, and cerebrospinal fluid (CSF) signals]. Two PD-ICD patients whose head motions exceeded 2 mm of translation or 2° of rotation throughout the scanning phase were eliminated from the experiment. Further, we calculated the mean FD of each subject and employed it as a covariate for subsequent inter-group comparisons of VMHC. The group comparisons of FD did not reveal any differences (<italic>p</italic> &gt; 0.05).</p>
        <p id="Par20">REST was also applied to analyze VMHC and the detailed operation sequences have been elaborated in previous literature (9). In short, for each subject, the Pearson correlation coefficient (r) was computed between a given voxel and its counterpart voxel in the contralateral hemisphere. Then, to improve the normality of the expected statistical distribution, the correlation r values were subject to Fisher z-transformed. The resulting values constituted the VMHC and were used for comparison in the following inter-group comparisons.</p>
        <p id="Par21">Then, a voxel-based comparison of VMHC maps among the three groups was performed. For the sake of excluding the possibility that VMHC differences created by specific factors, gender, age, education level, mean FD, MMSE, HAMA, and HAMD-24 scores were input as uninterested covariates in the ANCOVA analysis. Voxels that showed significant differences in the ANCOVA analysis were then subjected to post-hoc t-tests to determine the differences between each pair (voxel level &lt; 0.01, cluster size &gt; 17 voxels, corresponding to a corrected <italic>p</italic> &lt; 0.05 as determined by AlphaSim correction). AlphaSim is an approach which utilizes Monte Carrlo simulations to correct for multiple comparisons. Parameters included: single voxel <italic>p</italic> = 0.01; 1000 simulations; full width at half maximum = 6 mm; cluster connection radius <italic>r</italic> = 5 mm; and the mask of global gray matter.</p>
      </sec>
      <sec id="Sec14">
        <title>Cortical thickness</title>
        <p id="Par22">We further analyzed cortical thickness restricted to the brain regions showing significant differences in the VMHC analysis to explore whether these VMHC consequences were related to structural alternations. Cortical reconstruction and estimation of cortical thickness were carried out by FreeSurfer image analysis suite (<ext-link ext-link-type="uri" xlink:href="http://surfer.nmr.mgh.harvard.edu/">http://surfer.nmr.mgh.harvard.edu/</ext-link>, version 6.0) on the 3D T1-weighted images<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. The main procedures included: (1) automatic skull stripping to remove extra-cerebral structures, brainstem and cerebellum, (2) registration to Talairach space, (3) intensity normalization, (4) segmentation into white matter (WM), gray matter (GM), and CSF, (5) tessellation of the WM/GM borders, (6) automatic topology correction, (7) surface deformation to optimally set tissue boundaries<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>. The consequences of the segmentation process were visually censored by two clinicians who had no knowledge of participants. Then, we calculated the cortical thickness as the average shortest distance between the WM and GM surfaces at each vertex of the reconstructed cortical mantle.</p>
        <p id="Par23">To measure the degree of asymmetry in the thickness for each bilaterally cortical area, we introduced asymmetry index (AI) according to the following Eq. (<xref rid="Equ1" ref-type="">1</xref>)<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. R and L respectively represented the corresponding voxels’ cortical thickness values of the right and left hemispheres.<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$AI = \frac{{\left| {L - R} \right|}}{{L + R}} \times 100$$\end{document}</tex-math><mml:math id="M2"><mml:mrow><mml:mi>A</mml:mi><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mfenced close="∣" open="∣"><mml:mrow><mml:mi>L</mml:mi><mml:mo>−</mml:mo><mml:mi>R</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mo>+</mml:mo><mml:mi>R</mml:mi></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><graphic xlink:href="41531_2021_205_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par24">When L was greater than R, it meant “leftward asymmetric areas”. When R was greater than L, it represented “rightward asymmetric areas”. We believed that when the AIs values of a subject with ICD or no-ICD were less than those HCs, the degree of cortical asymmetry was reduced, and vice versa. Adjusted for age, sex, degree of education, the AI values of the three groups were analyzed by ANCOVA. Here, we only analyzed the brain regions which showing significant differences in the above VMHC comparisons. Correction for multiple comparisons (Bonferroni, <italic>p</italic> &lt; 0.05) was applied to threshold analyses.</p>
      </sec>
      <sec id="Sec15">
        <title>TBSS</title>
        <p id="Par25">TBSS was applied to compare fiber tracts impairment across the whole brain among three groups. The detailed content of DTI images acquisition, preprocessing and TBSS analyses was illustrated in the supplemental materials.</p>
      </sec>
      <sec id="Sec16">
        <title>Statistical analysis</title>
        <p id="Par26">The data were analyzed using IBM SPSS statistics 20.0 (Chicago, IL, USA). Sociodemographic and clinical characteristics were compared by two-sample t-test, Chi square test, Mann-Whitney test, Kruskal-Wallis test and one-way analysis of variance (ANOVA), as appropriate. The Bonferroni correction was also performed. Besides, we extracted the brain region exhibiting significant differences between the PD-ICD and PD-no ICD group as ROI. Partial correlation analysis was employed to compute correlation between the mean VMHC values of the selected ROI and the QUIP-RS scores in PD patients with ICD. LEDD, disease duration and age at onset, MMSE, HAMA, and HAMD-24 scores were included as covariates.</p>
        <p id="Par27">The extracted brain regions were further evaluated by ROC curves to assess whether they could be deemed as ICD recognition features. The specificity, sensitivity, and area AUC were described for cut-off values. Optimal cut-off was chosen by maximizing Youden’s index.</p>
      </sec>
      <sec id="Sec17">
        <title>Reporting summary</title>
        <p id="Par28">Further information on research design is available in the Nature Research Reporting Summary linked to this article.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <sec id="Sec18">
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="41531_2021_205_MOESM1_ESM.pdf">
            <caption>
              <p>Supplementary Information</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="41531_2021_205_MOESM2_ESM.pdf">
            <caption>
              <p>Reporting Summary</p>
            </caption>
          </media>
        </supplementary-material>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
      <fn>
        <p>These authors contributed equally: Caiting Gan, Lina Wang, Min Ji.</p>
      </fn>
    </fn-group>
    <sec>
      <title>Supplementary information</title>
      <p>The online version contains supplementary material available at 10.1038/s41531-021-00205-7.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>This work was supported by the National Natural Science Foundation of China (Nos. 81901297 and 81671258). We are grateful to all of the study participants for their patience and cooperation.</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>Caiting Gan: conception and design of study, acquisition of clinical data, statistical analysis, writing of the first draft. Lina Wang: acquisition of MRI data, statistical analysis, revision the manuscript. Min Ji: conception and design of study, acquisition of clinical data. Kewei Ma: acquisition of clinical data, revision the manuscript. Huimin Sun: acquisition of clinical data, revision the manuscript. Kezhong Zhang: conception and design of study, revision the manuscript, study supervision, obtaining funding. Yongsheng Yuan: conception and design of study, revision the manuscript, study supervision, obtaining funding.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Data availability</title>
      <p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p>
    </notes>
    <notes id="FPar1" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par29">All authors declare no competing interest.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferrara</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Stacy</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Impulse-control disorders in Parkinson’s disease</article-title>
          <source>CNS Spectr.</source>
          <year>2008</year>
          <volume>13</volume>
          <fpage>690</fpage>
          <pub-id pub-id-type="doi">10.1017/S1092852900013778</pub-id>
          <pub-id pub-id-type="pmid">18704024</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Callesen</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Scheel-Kruger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kringelbach</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Moller</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A systematic review of impulse control disorders in Parkinson’s disease</article-title>
          <source>J. Parkinsons Dis.</source>
          <year>2013</year>
          <volume>3</volume>
          <fpage>105</fpage>
          <pub-id pub-id-type="doi">10.3233/JPD-120165</pub-id>
          <pub-id pub-id-type="pmid">23938342</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Voon</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impulse control disorders in Parkinson disease: a multicenter case–control study</article-title>
          <source>Ann Neurol.</source>
          <year>2011</year>
          <volume>69</volume>
          <fpage>986</fpage>
          <pub-id pub-id-type="doi">10.1002/ana.22356</pub-id>
          <pub-id pub-id-type="pmid">21416496</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gatto</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Aldinio</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Impulse control disorders in Parkinson’s disease. A brief and comprehensive review</article-title>
          <source>Front Neurol</source>
          <year>2019</year>
          <volume>10</volume>
          <fpage>351</fpage>
          <pub-id pub-id-type="doi">10.3389/fneur.2019.00351</pub-id>
          <pub-id pub-id-type="pmid">31057473</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Grace</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior</article-title>
          <source>Nat. Neurosci.</source>
          <year>2005</year>
          <volume>8</volume>
          <fpage>805</fpage>
          <pub-id pub-id-type="doi">10.1038/nn1471</pub-id>
          <pub-id pub-id-type="pmid">15908948</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mosley</surname>
              <given-names>PE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The structural connectivity of discrete networks underlies impulsivity and gambling in Parkinson’s disease</article-title>
          <source>Brain</source>
          <year>2019</year>
          <volume>142</volume>
          <fpage>3917</fpage>
          <pub-id pub-id-type="doi">10.1093/brain/awz327</pub-id>
          <pub-id pub-id-type="pmid">31665241</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barone</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Risk factors for impulse control disorders and related behaviors in Parkinson’s disease: secondary analyses of the ICARUS study</article-title>
          <source>J. Drug Assess.</source>
          <year>2019</year>
          <volume>8</volume>
          <fpage>159</fpage>
          <pub-id pub-id-type="doi">10.1080/21556660.2019.1675670</pub-id>
          <pub-id pub-id-type="pmid">31700703</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phillipps</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Is motor side onset of Parkinson’s disease a risk factor for developing impulsive-compulsive behavior? A cross-sectional study</article-title>
          <source>Mov. Disord.</source>
          <year>2020</year>
          <volume>35</volume>
          <fpage>1080</fpage>
          <pub-id pub-id-type="doi">10.1002/mds.28053</pub-id>
          <pub-id pub-id-type="pmid">32311121</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Premi</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impulse control disorder in PD: a lateralized monoaminergic frontostriatal disconnection syndrome?</article-title>
          <source>Parkinsonism Relat. Disord.</source>
          <year>2016</year>
          <volume>30</volume>
          <fpage>62</fpage>
          <pub-id pub-id-type="doi">10.1016/j.parkreldis.2016.05.028</pub-id>
          <pub-id pub-id-type="pmid">27264342</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zuo</surname>
              <given-names>XN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Growing together and growing apart: regional and sex differences in the lifespan developmental trajectories of functional homotopy</article-title>
          <source>J. Neurosci.</source>
          <year>2010</year>
          <volume>30</volume>
          <fpage>15034</fpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2612-10.2010</pub-id>
          <pub-id pub-id-type="pmid">21068309</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hung</surname>
              <given-names>SC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Early recovery of interhemispheric functional connectivity after corpus callosotomy</article-title>
          <source>Epilepsia</source>
          <year>2019</year>
          <volume>60</volume>
          <fpage>1126</fpage>
          <pub-id pub-id-type="pmid">31087658</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Aberrant interhemispheric homotopic functional and structural connectivity in amyotrophic lateral sclerosis</article-title>
          <source>J. Neurol. Neurosurg. Psychiatry</source>
          <year>2017</year>
          <volume>88</volume>
          <fpage>369</fpage>
          <pub-id pub-id-type="doi">10.1136/jnnp-2016-314567</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hou</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Reduction of interhemispheric functional brain connectivity in early blindness: a resting-state fMRI study</article-title>
          <source>Biomed. Res. Int.</source>
          <year>2017</year>
          <volume>2017</volume>
          <fpage>6756927</fpage>
          <pub-id pub-id-type="pmid">28656145</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hardee</surname>
              <given-names>JE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Development of impulse control circuitry in children of alcoholics</article-title>
          <source>Biol. Psychiatry</source>
          <year>2014</year>
          <volume>76</volume>
          <fpage>708</fpage>
          <pub-id pub-id-type="doi">10.1016/j.biopsych.2014.03.005</pub-id>
          <pub-id pub-id-type="pmid">24742620</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Sinha</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction</article-title>
          <source>Neurosci. Biobehav. Rev.</source>
          <year>2008</year>
          <volume>32</volume>
          <fpage>581</fpage>
          <pub-id pub-id-type="doi">10.1016/j.neubiorev.2007.10.003</pub-id>
          <pub-id pub-id-type="pmid">18164058</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <mixed-citation publication-type="other">Wang L. et al. Enhanced neural responses in specific phases of reward processing in individuals with Internet gaming disorder. <italic>J. Behav. Addict.</italic> (2021).</mixed-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Hairston</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schrier</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Common and distinct networks underlying reward valence and processing stages: a meta-analysis of functional neuroimaging studies</article-title>
          <source>Neurosci. Biobehav. Rev.</source>
          <year>2011</year>
          <volume>35</volume>
          <fpage>1219</fpage>
          <pub-id pub-id-type="doi">10.1016/j.neubiorev.2010.12.012</pub-id>
          <pub-id pub-id-type="pmid">21185861</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jahfari</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effective connectivity reveals important roles for both the hyperdirect (fronto-subthalamic) and the indirect (fronto-striatal-pallidal) fronto-basal ganglia pathways during response inhibition</article-title>
          <source>J. Neurosci.</source>
          <year>2011</year>
          <volume>31</volume>
          <fpage>6891</fpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5253-10.2011</pub-id>
          <pub-id pub-id-type="pmid">21543619</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castrioto</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Iowa gambling task impairment in Parkinson’s disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation</article-title>
          <source>J. Neurol. Neurosurg. Psychiatry</source>
          <year>2015</year>
          <volume>86</volume>
          <fpage>186</fpage>
          <pub-id pub-id-type="doi">10.1136/jnnp-2013-307146</pub-id>
          <pub-id pub-id-type="pmid">24860137</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Voon</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impulse control disorders and levodopa-induced dyskinesias in Parkinson’s disease: an update</article-title>
          <source>Lancet Neurol.</source>
          <year>2017</year>
          <volume>16</volume>
          <fpage>238</fpage>
          <pub-id pub-id-type="doi">10.1016/S1474-4422(17)30004-2</pub-id>
          <pub-id pub-id-type="pmid">28229895</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Biundo</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Patterns of cortical thickness associated with impulse control disorders in Parkinson’s disease</article-title>
          <source>Mov. Disord.</source>
          <year>2015</year>
          <volume>30</volume>
          <fpage>688</fpage>
          <pub-id pub-id-type="doi">10.1002/mds.26154</pub-id>
          <pub-id pub-id-type="pmid">25649923</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Holst</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>van Holstein</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>van den Brink</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Veltman</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Goudriaan</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
          <article-title>Response inhibition during cue reactivity in problem gamblers: an fMRI study</article-title>
          <source>PLoS ONE</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>e30909</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0030909</pub-id>
          <pub-id pub-id-type="pmid">22479305</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reuter</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pathological gambling is linked to reduced activation of the mesolimbic reward system</article-title>
          <source>Nat. Neurosci.</source>
          <year>2005</year>
          <volume>8</volume>
          <fpage>147</fpage>
          <pub-id pub-id-type="doi">10.1038/nn1378</pub-id>
          <pub-id pub-id-type="pmid">15643429</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paz-Alonso</surname>
              <given-names>PM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional inhibitory control dynamics in impulse control disorders in Parkinson’s disease</article-title>
          <source>Mov. Disord.</source>
          <year>2020</year>
          <volume>35</volume>
          <fpage>316</fpage>
          <pub-id pub-id-type="doi">10.1002/mds.27885</pub-id>
          <pub-id pub-id-type="pmid">31710401</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carriere</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Defebvre</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Delmaire</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dujardin</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease</article-title>
          <source>Neurology</source>
          <year>2015</year>
          <volume>84</volume>
          <fpage>2116</fpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0000000000001619</pub-id>
          <pub-id pub-id-type="pmid">25925985</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Imperiale</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brain structural and functional signatures of impulsive-compulsive behaviours in Parkinson’s disease</article-title>
          <source>Mol. Psychiatry</source>
          <year>2018</year>
          <volume>23</volume>
          <fpage>459</fpage>
          <pub-id pub-id-type="doi">10.1038/mp.2017.18</pub-id>
          <pub-id pub-id-type="pmid">28265121</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weintraub</surname>
              <given-names>Daniel</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease</article-title>
          <source>Movement Disord.</source>
          <year>2009</year>
          <volume>24</volume>
          <fpage>1461</fpage>
          <pub-id pub-id-type="doi">10.1002/mds.22571</pub-id>
          <pub-id pub-id-type="pmid">19452562</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weintraub</surname>
              <given-names>Daniel</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Questionnaire for impulsive-compulsive disorders in Parkinson’s disease-rating scale</article-title>
          <source>Movement Disord.</source>
          <year>2012</year>
          <volume>27</volume>
          <fpage>242</fpage>
          <pub-id pub-id-type="doi">10.1002/mds.24023</pub-id>
          <pub-id pub-id-type="pmid">22134954</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guerra</surname>
              <given-names>DF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Measurement properties from the Brazilian Portuguese version of the QUIP-RS</article-title>
          <source>NPJ Parkinsons Dis.</source>
          <year>2020</year>
          <volume>6</volume>
          <fpage>6</fpage>
          <pub-id pub-id-type="doi">10.1038/s41531-020-0108-2</pub-id>
          <pub-id pub-id-type="pmid">32128360</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tomlinson Claire</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Systematic review of levodopa dose equivalency reporting in Parkinson’s disease</article-title>
          <source>Movement Disord.</source>
          <year>2010</year>
          <volume>25</volume>
          <fpage>2649</fpage>
          <pub-id pub-id-type="doi">10.1002/mds.23429</pub-id>
          <pub-id pub-id-type="pmid">21069833</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fischl</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dale</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Measuring the thickness of the human cerebral cortex from magnetic resonance images</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2000</year>
          <volume>97</volume>
          <fpage>11050</fpage>
          <pub-id pub-id-type="doi">10.1073/pnas.200033797</pub-id>
          <pub-id pub-id-type="pmid">10984517</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dale</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Fischl</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sereno</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
          <article-title>Cortical surface-based analysis. I. Segmentation and surface reconstruction</article-title>
          <source>Neuroimage</source>
          <year>1999</year>
          <volume>9</volume>
          <fpage>179</fpage>
          <pub-id pub-id-type="doi">10.1006/nimg.1998.0395</pub-id>
          <pub-id pub-id-type="pmid">9931268</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Segonne</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pacheco</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fischl</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Geometrically accurate topology-correction of cortical surfaces using nonseparating loops</article-title>
          <source>IEEE Trans. Med Imaging</source>
          <year>2007</year>
          <volume>26</volume>
          <fpage>518</fpage>
          <pub-id pub-id-type="doi">10.1109/TMI.2006.887364</pub-id>
          <pub-id pub-id-type="pmid">17427739</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>JongHun</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cortical asymmetries in normal, mild cognitive impairment, and Alzheimer’s disease</article-title>
          <source>Neurobiol. Aging</source>
          <year>2012</year>
          <volume>33</volume>
          <fpage>1959</fpage>
          <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2011.06.026</pub-id>
          <pub-id pub-id-type="pmid">21907459</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
